allosteric IRF5 inhibitor (HotSpot Therapuetics/AbbVie)

N/A

Report date: 2025/03/14 16:30:34
NME

Base Information

Drug Nameallosteric IRF5 inhibitor (HotSpot Therapuetics/AbbVie)
Drug Alias NameIFN regulatory factor 5-targeting allosteric inhibitor (HotSpot/AddVie)IFN regulatory factor 5-targeting allosteric inhibitor (HotSpot)IRF5 selective antagonist (HotSpot Therapeutics)allosteric IRF5 inhibitor (HotSpot Therapuetics)IRF5 selective antagonist (HotSpot Therapeutics/AbbVie)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterferon regulatory factor 5 inhibitors
TargetsInterferon regulatory factor 5
Therapy Area/IndicationsAutoimmune DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHotSpot Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAbbvie IncHotSpot Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A